1-10 of 10
Oliver Cornely
Close
Sort by
Journal Articles

Decoding the Historical TALE: COVID-19 Impact on Hematological Malignancy Patients - Insights from 2020 to 2022

Francesco Marchesi, Jon Salmanton-García, Francesca Farina, Barbora Weinbergerova, Federico Itri, Julio Dávila-Valls, Sonia Martín-Pérez, Andreas Glenthoej, Ditte Hersby, Maria Gomes Da Silva, Raquel Nunes-Rodrigues, Raul Cordoba, Alberto Lopez Garcia, Ziad Emarah, Shaimaa El-Ashwah, Yavuz M. Bilgin, Laman Rahimli, Oliver Cornely, Livio Pagano
Journal: Blood
Blood (2023) 142 (Supplement 1): 1067.
https://doi.org/10.1182/blood-2023-188942
Published: 2023
Journal Articles

Clinical Outcome of Covid-19 in Haematologic Malignancy Patients with a Fourth Dose of Anti-Sars-Cov-2 Vaccine: A Final Epicovideha Report

Meinolf Karthaus, Jon Salmanton-García, Francesco Marchesi, Andreas Glenthoej, Yavuz M Bilgin, Jens Van Praet, Laman Rahimli, Oliver Cornely, Livio Pagano
Journal: Blood
Blood (2023) 142 (Supplement 1): 7262.
https://doi.org/10.1182/blood-2023-189041
Published: 2023
Journal Articles

A Phase 3 Randomized Controlled Trial (MICROCARE) to Evaluate the Efficacy of DAV132 in Preventing Clostridioides Difficile Infection in Patients with Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome and Treated with Intensive Chemotherapy

Maria Vehreschild, Cornelis H. van Werkhoven, Lena Biehl, Aaron Dane, Marlieke E.A. de Kraker, France Mentré, Charles Burdet, Gérald Glupczynski, Leen Timbermont, Elodie Pfender, Frédérique Sablier-Gallis, Antoine Andremont, Jean de Gunzburg, Renaud Buffet, Mark Wilcox, Oliver Cornely, Marc Bonten, Fabien Vitry
Journal: Blood
Blood (2021) 138 (Supplement 1): 4437.
https://doi.org/10.1182/blood-2021-146501
Published: 2021
Journal Articles

COVID-19 Infection in Vaccinated Adult Patients with Hematological Malignancies. Preliminary Results from Epicovideha (Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey)

Francesco Marchesi, Jon Salmanton-García, Alberto Lopez-Garcia, Giulia Dragonetti, Uluhan Sili, Andreas Glenthoej, Caterina Buquicchio, Malgorzata Mikulska, Barbora Weinbergerova, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Nikolay N. Klimko, Antonio Pagliuca, Francesco Passamonti, Philipp Köhler, Oliver Cornely, Livio Pagano
Journal: Blood
Blood (2021) 138 (Supplement 1): 3733.
https://doi.org/10.1182/blood-2021-147295
Published: 2021
Journal Articles

The Prosid Study: Evaluating Efficacy and Safety of Intravenous Immunoglobulin (IVIG) 10% in Primary Infection Prophylaxis in Patients with Chronic Lymphocytic Leukemia- Study Design

Oliver Cornely, MD, Anthony Mato, MD, Tadeusz Robak, MDPhD, Sibylle Mellinghoff, MD, Tatiana Lavrova, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-136898
Published: 2020
Journal Articles

Invasive Mucormycosis in Patients with Hematological Diseases Identified in the Global Fungiscope Registry

Meinolf Karthaus, MD, Luisa Duran Graeff, MD, Maria J.G.T. Vehreschild, MD, Arne Meißner, MD, Jon Salmanton-Garcia, Philipp Köhler, MD, Hilmar Wisplinghoff, MD, J. Janne Vehreschild, MD, Oliver Cornely, MD, Danila Seidel, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5649.
https://doi.org/10.1182/blood.V130.Suppl_1.5649.5649
Published: 2017
Journal Articles

Aspergillus Specific PCR and Galactomannan of Bronchoalveolar Lavage Are Superior to Concomitant Same-Day Testing of Concurrent Blood Samples in Immunocompromised Hematological Patients with Suspected Invasive Aspergillosis

Tobias Boch, MD, Birgit Spiess, PhD, Oliver Cornely, MD, Werner J. Heinz, MD, Joachim Hahn, MD, Stefan W. Krause, MD, Hartmut Bertz, MD, Wolf-Karsten Hofmann, MD, Dieter Buchheidt, MD, Mark Reinwald, MD
Journal: Blood
Blood (2015) 126 (23): 2072.
https://doi.org/10.1182/blood.V126.23.2072.2072
Published: 2015
Journal Articles

A Double-Blind, Multicentre, Randomised, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of Prophylactic Liposomal Amphotericin B (AmBisome®) for the Prevention of Invasive Fungal Infections in Subjects Receiving Remission-Induction Chemotherapy for Acute Lymphoblastic Leukaemia (AmBiGuard trial)

Oliver Cornely, MD, Thibaut Leguay, MD, Johan Maertens, MD, Carlo Castagnola, MD, Achilles Anagnostopoulos, Bernadino Allione, MD, Claus Peter Heussel, MD, J Peter Donnelly, PhD, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, MD, Nicola Goekbuget, MD
Journal: Blood
Blood (2014) 124 (21): 3646.
https://doi.org/10.1182/blood.V124.21.3646.3646
Published: 2014
Journal Articles

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: a retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Clinical Trials & Observations
Rodrigo Martino, Rocio Parody, Takahiro Fukuda, Johan Maertens, Koen Theunissen, Aloysius Ho, Ghulam J. Mufti, Nicolaus Kroger, Arnold R. Zander, Dominik Heim, Monika Paluszewska, Dominik Selleslag, Katerina Steinerova, Per Ljungman, Simone Cesaro, Anna Nihtinen, Catherine Cordonnier, Lourdes Vazquez, Monica López-Duarte, Javier Lopez, Rafael Cabrera, Montserrat Rovira, Stefan Neuburger, Oliver Cornely, Ann E. Hunter, Kieren A. Marr, Hans Jürgen Dornbusch, Hermann Einsele
Journal: Blood
Blood (2006) 108 (9): 2928–2936.
https://doi.org/10.1182/blood-2006-03-008706
Published: 2006
Journal Articles

PEG-Interferon for Chronic Phase CML - Still an Option in the Era of Imatinib?.

Christof Scheid, MD, Andreas Draube, MD, Udo Holtick, MD, Oliver Cornely, MD, Ulrich Hacker, MD, Michael Fuchs, MD, Ute Berger, MD, Andreas Hochhaus, MD, PhD, Rüdiger Hehlmann, MD, PhD, Michael Hallek, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4662.
https://doi.org/10.1182/blood.V104.11.4662.4662
Published: 2004